Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.80 | 23.33 |
| PEG Ratio (TTM) | 0.26 | 2.78 |
| P/S Ratio (TTM) | 0.60 | 7.23 |
| P/B Ratio (TTM) | 0.55 | 7.38 |
| P/FCF Ratio (TTM) | N/A | 34.33 |
| Price to 5YR AVG Earnings Ratio | N/A | 37.21 |
| Price to 5YR AVG FCF Ratio | N/A | 44.76 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -10.31% | 19.76% |
| ROE (TTM) | -13.85% | 28.18% |
| Net Profit Margin (TTM) | -15.54% | 1.28% |
| ROIC 5YR AVG | N/A | 24.90% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -192.06% | -36.13% | N/A |
| Revenue | -2.29% | 80.78% | N/A |
| Net Income | 13.53% | -41.34% | N/A |
| Cash Flow | N/A | -55.85% | N/A |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.48 | 2.38 |
| Quick Ratio (TTM) | 3.44 | 2.38 |
| D/E Ratio (TTM) | 0.02 | 0.04 |
| Interest Coverage (TTM) | N/A | 226.14 |
| Piotroski F-Score | 5 | 7 |
| Altman Z-Score | 1.26 | 13.33 |
| LTL to 5YR AVG FCF | N/A | 0.48 |
| Shares Outstanding Growth 5YR AVG | N/A | -1.41% |